A recent study conducted at the University of Berne Equine Clinic in Switzerland demonstrated that the prokinetic (promoting movement) drug tegaserod stimulated gut motility and accelerated gastrointestinal transit in healthy horses. The study findings, published in the Equine Veterinary Journal, are consistent with those observed in large clinical trials involving human patients and in studies of other animal species.

According to lead investigator Britta Lippold, DVM, “Our data suggest that tegaserod, given intravenously, might be useful for the treatment of paralytic ileus after colic surgery, or as an adjunct therapy for horses suffering from impaction